BioSpace News Archive

Bio NC

Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report

Global biopharma R&D productivity rebounded in 2023 with higher composite success rates enabled by industry-wide and regulator adoption of data and technology driven innovation, including novel trial design, optimized biomarker use, and digital and decentralized trial methodologies.

February 23, 2024

·

7 min read

Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report

Sanofi announces the filing of its Form 20-F with the U.S. Securities and Exchange Commission and its “Document d’Enregistrement Universel” containing its Annual Financial Report with the French market regulator Autorité des marchés financiers.

February 23, 2024

·

1 min read

Job Trends

MODERNA CELEBRATES CONSTRUCTION COMPLETION OF CANADIAN MRNA MANUFACTURING FACILITY

Moderna today announced the completion of construction of its state-of-the art mRNA manufacturing facility in Laval, Quebec.

February 23, 2024

·

5 min read

BioMidwest

CAP Updates Validation of Immunohistochemical Assays Testing Guideline for Precise Results, Improved Patient Care

The College of American Pathologists (CAP) updated the “Principles of Analytic Validation of Immunohistochemical Assays” guideline to provide increased precision and accuracy of clinical immunohistochemical assays.

February 23, 2024

·

3 min read

Biotech Bay

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 23, 2024

Ultragenyx Pharmaceutical Inc. reported the grant of 10,995 restricted stock units of the company’s common stock to nine newly hired non-executive officers of the company.

February 23, 2024

·

1 min read

Pharm Country

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 23, 2024

TELA Bio, Inc. announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 5,800 shares of its common stock to five newly-hired employees, with a grant date of February 21, 2024.

February 23, 2024

·

2 min read

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

China Pharma Holdings Inc. reported that it expects to implement a 1-for-5 reverse stock split on its common stock effective Wednesday, March 6, 2024, with trading to begin on a split-adjusted basis at the market open on that day.

February 23, 2024

·

3 min read

Business

AbCellera Announces Resignation of Board Member

AbCellera (Nasdaq: ABCL) today announced that Peter Thiel has notified the Company of his intention to resign from the Company’s Board of Directors for personal reasons, effective March 7, 2024.

February 23, 2024

·

3 min read

Biotech Beach

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

CSL Vifor and Travere Therapeutics, Inc., announced that the European Medicines Agency’s CHMP has recommended approval of sparsentan for the treatment of adults with primary IgAN with a urine protein excretion >1.0 g/day. IgAN is a rare kidney disorder and a leading cause of kidney failure.

February 23, 2024

·

5 min read

Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference

Protalix BioTherapeutics, Inc. (NYSE American: PLX) today announced that it will attend and present at the 2024 BIO CEO & Investor Conference taking place February 26-27, 2024 at the New York Marriott Marquis in New York City.

February 23, 2024

·

2 min read